by [email protected] | May 20, 2019 | Publication, Rare Diseases
Abstract Authors: Keshishian A, Greenberg SA, Agashivala N, Baser O. Johnson K. Objective: This study identifies the health care costs and utilization, as well as comorbidities, in a Medicare population of inclusion body myositis (IBM) patients....
by [email protected] | May 18, 2019 | Mental Health, Publication
Abstract Authors: Pesa JA, Doshi D, Wang L, Yuce H, Baser O. Objective: To compare all-cause health care utilization and costs between patients with schizophrenia treated with once monthly paliperidone palmitate (PP1M; Invega Sustenna) and atypical oral antipsychotic...
by [email protected] | May 13, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Bui CN, Wang L, Baser O. Objectives: Corticosteroids (CSs) are used concomitantly with life-extending therapies (LETs) in patients with castration-resistant prostate cancer (CRPC). This study examined time to LETs, LETs and concomitant CS...
by [email protected] | May 8, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Baser O, Wei W, Henk HJ, Teitelbaum A, Xie L. Background: Triple-negative breast cancer (TNBC) makes up 10-17% of all breast cancers and, due to lack of receptor expression, is unresponsive to therapies that target hormonal receptors or HER2....
by [email protected] | May 1, 2019 | Cardiovascular, Publication
Abstract Objective: To compare the risk and cost of stroke/systemic embolism (SE) and major bleeding between each direct oral anticoagulant (DOAC) and warfarin among non-valvular atrial fibrillation (NVAF) patients. Methods: Patients (≥65 years) initiating warfarin or...
